Asia
Now that global responses are fully mobilized, what is being done to identify and develop drugs and vaccines against this novel coronavirus?
Eisai indicated it was voluntarily withdrawing the drug, but in a statement noted it disagreed with the FDA’s interpretation of the data and believes the drug’s benefits outweigh the cancer risk.
Vela Diagnostics Submitting Novel Coronavirus Diagnostic Test to FDA for Emergency Use Authorization
Vela Diagnostics has developed the ViroKeyTM SA201 COVID-19 RT-PCR Test, a new diagnostic test for the detection of the COVID-19 coronavirus. Vela Diagnostics is currently in discussions with the U.S. Food and Drug Administration for clearance of the test under the emergency use authorization.
There is a significant amount of work being done on cardiovascular diseases. Here’s a look at just some of the recent news.
The outbreak of the coronavirus, now called COVID-19, is taking some unexpected twists and turns.
The company’s efforts appear to be working, as it reported fourth-quarter results that exceeded expectations. Company shares popped 9.1% at the news.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
The World Health Organization (WHO) gave the coronavirus that began in Wuhan, China, an official name, COVID-19.
A single AQP5+ human gastric stem cell gives rise to a 3D gastric organoid that re-expresses AQP5.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
PRESS RELEASES